Replimune Reports Second Fiscal Quarter Financial Results and Provides Corporate Update

NEXT STORY
Corbus Pharmaceuticals Updates Data from Lenabasum Open-Label Extension Studies in Systemic Sclerosis and Dermatomyositis at 2019 ACR Annual Meeting
PREV STORY
Flexion Therapeutics Presents ZILRETTA® (triamcinolone acetonide extended-release injectable suspension) Efficacy Data at the AAHKS and ACR Annual Meetings
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Affimed to Report 3rd Quarter 2020 Financial Results & Corporate Update November 10, 2020

author_avatar
NASDAQ Market News

Animal Health Market size 2021 | Is anticipated to reach USD 67.56 billion with a CAGR of 6.3% by 2026

author_avatar
NASDAQ Market News

Turning Point Therapeutics Announces Initial Clinical Data From Phase 1/2 SWORD-1 Study of RET Inhibitor TPX-0046

author_avatar
NASDAQ Market News